ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1259

Characteristics of Sacroiliac Joint in Patient with Skin Psoriasis, Without Rheumatological Manifestations: A Controlled Study Using CT Scan

Thomas Leriche1, Olivier Fakih2, Clément Prati1, Daniel Wendling3 and Frank Verhoeven4, 1CHU de Besançon, Besançon, France, 2Service de rhumatologie, CHU de Besançon, Besançon, France, 3CHU, University Teaching Hospital, Besançon, France, 4Besançon University Hospital, Rheumatology Department, Besançon, France

Meeting: ACR Convergence 2022

Keywords: Imaging, Psoriatic arthritis, skin, X-ray

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Imaging of Rheumatic Diseases Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Plaque Psoriasis (PsO) is an inflammatory disorder that could be associated with rheumatological manifestations defining Psoriatic arthritis. Moreover, recent studies showed that the presence of plaque psoriasis is associated with more structural damage In axial Spondyloarthritis (1). To our knowledge, no study has specifically evaluated the extent of structural lesions of the sacroiliac joints (SIJs) on computed tomography (CT) in patients with PsO, without rheumatological manifestations, compared with healthy controls. The objective of this study is to describe SIJ CT characteristics in patients with PsA and compare them with those of age- and sex- matched controls.

Methods: An observational, retrospective study was performed using medical records from Besançon University Hospital’s rheumatology and dermatology departments, which were screened to identify patients with PsO, diagnosed by a dermatologist. A search was then carried out for patients in the hospitals’ imaging archiving system to identify those who had undergone a CT which included the SIJs in their entirety. Non-inclusion criteria were the existence of pelvic bone lesions and a history of pelvic radiotherapy. Each patient was then matched with a control of the same age and sex, recruited through the hospital’s imaging archiving system.

For each individual, CT was interpreted by two independent readers using a score previously used by Diekhoff et al. [2], dividing each SIJ into 12 regions, for each of which joint space narrowing (JSN), erosions, and sclerosis are assessed. For this study, we also observed the existence of intra-articular gas and diffuse idiopathic skeletal hyperostosis (DISH) lesions for each region. Quantitative variables were compared using Student’s t-test. Qualitative variables were compared using the Chi-2 test.

Results: 60 patients and 57controls were included. Mean (SD) age was 52,2 ± 17,7 in the PsO group and 53,6 ± 16.7 in the control group. 31 (52%) were male in PsO group and 30 (54%) in the control group. In the PsO group, BMI was 27,7± 6 versus 26,9 ± 6,44 in control group (p= 0.55). There is a trend for more frequent active smoking in PsO (69% in PsO group versus 54% in control group; p=0.075) . In PsO patients, mean disease duration was 20.2 ± 17,6 years, the skin area affected was 41,8% ± 22,6 and the mean number of bDMARDs used was 2.25 (± 1.16). The global SIJ score was higher in the PsO group (6,63 ± 10,7) in comparison with the control group (2,84 ± 4,87). Erosion and sclerosis scores were similar in both group but joint space narrowing score was significantly higher in the PsO group (0.873 (±4.62) versus 4.15 (±10.8); p =0.035). There were no correlations between the global score and the disease duration (Pearson score 0.166 (-0.131; 0.435)) and the severity of the psoriasis (Pearson 0.00937 (-0.259; 0.276)). The number of gestation, active smoking, alcohol intake and physical work have no impact on the global Score.

Conclusion: The CT characteristics of SIJ frompatients with PsO were different to those of age and sex-matched controls essentially secondary to joint space narrowing.


Disclosures: T. Leriche, None; O. Fakih, None; C. Prati, None; D. Wendling, AbbVie/Abbott, Bristol-Myers Squibb(BMS), Merck/MSD, Pfizer, Roche, Amgen, Nordic Pharma, UCB, Novartis, Janssen, Eli Lilly, Sandoz, Galapados, Grunenthal; F. Verhoeven, None.

To cite this abstract in AMA style:

Leriche T, Fakih O, Prati C, Wendling D, Verhoeven F. Characteristics of Sacroiliac Joint in Patient with Skin Psoriasis, Without Rheumatological Manifestations: A Controlled Study Using CT Scan [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/characteristics-of-sacroiliac-joint-in-patient-with-skin-psoriasis-without-rheumatological-manifestations-a-controlled-study-using-ct-scan/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-sacroiliac-joint-in-patient-with-skin-psoriasis-without-rheumatological-manifestations-a-controlled-study-using-ct-scan/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology